BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mandolini GM, Lazzaretti M, Pigoni A, Oldani L, Delvecchio G, Brambilla P. Pharmacological properties of cannabidiol in the treatment of psychiatric disorders: a critical overview. Epidemiol Psychiatr Sci 2018;27:327-35. [PMID: 29789034 DOI: 10.1017/S2045796018000239] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 9.2] [Reference Citation Analysis]
Number Citing Articles
1 Hajirahimkhan S, Hefferon K, Jackowetz N. The Functional Compounds of Cannabis sativa. Reference Module in Food Science 2023. [DOI: 10.1016/b978-0-12-823960-5.00044-5] [Reference Citation Analysis]
2 Cassiani-miranda CA, Arango-dávila CA, González-giraldo J, Parra-vera MD, Tellez-vargas J, Morales-puerto LR. Consenso colombiano del tratamiento con cannabidiol (CBD) puro en psiquiatría. Revista Colombiana de Psiquiatría 2023. [DOI: 10.1016/j.rcp.2022.10.007] [Reference Citation Analysis]
3 Jin Z, Zhan Y, Zheng L, Wei Q, Xu S, Qin Z. Cannabidiol-loaded poly lactic-co-glycolic acid nanoparticles with improved bioavailability as a potential for osteoarthritis therapeutic.. [DOI: 10.21203/rs.3.rs-2304218/v1] [Reference Citation Analysis]
4 Ioannidis K, Tomprou I, Mitsis V. An Alternative In Vitro Propagation Protocol of Cannabis sativa L. (Cannabaceae) Presenting Efficient Rooting, for Commercial Production. Plants 2022;11:1333. [DOI: 10.3390/plants11101333] [Reference Citation Analysis]
5 Karimi-Haghighi S, Razavi Y, Iezzi D, Scheyer AF, Manzoni O, Haghparast A. Cannabidiol and substance use disorder: Dream or reality. Neuropharmacology 2022;207:108948. [PMID: 35032495 DOI: 10.1016/j.neuropharm.2022.108948] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Alayli AFG, Kotz D, Kastaun S. Recreational Cannabidiol: Awareness, Prevalence of use, and Associated Factors in a Representative Sample of the German Population. Subst Use Misuse 2022;57:1417-24. [PMID: 35686726 DOI: 10.1080/10826084.2022.2083175] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Özenver N. Cannabis in Healthcare: Ethnobotanical and Pharmaceutical Perspectives and Legal Status in Turkey and the Middle East. Cannabis/Marijuana for Healthcare 2022. [DOI: 10.1007/978-981-16-8822-5_7] [Reference Citation Analysis]
8 Cleirec G, Desmier E, Lacatus C, Lesgourgues S, Braun A, Peloso C, Obadia C. Efficiency of Inhaled Cannabidiol in Cannabis Use Disorder: The Pilot Study Cannavap. Front Psychiatry 2022;13:899221. [PMID: 35686188 DOI: 10.3389/fpsyt.2022.899221] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Kloiber S, Matheson J, Kim HK, Le Foll B. Cannabinoid Drugs in Mental Health Disorders. NeuroPsychopharmacotherapy 2022. [DOI: 10.1007/978-3-030-62059-2_465] [Reference Citation Analysis]
10 Daldegan-Bueno D, Lindner SR, Fischer B. Conceptualizing and considering Cannabis-Related "Harm-to-Others": The Role of Cannabis-Related Violence. Subst Use Misuse 2022;57:1488-91. [PMID: 35730558 DOI: 10.1080/10826084.2022.2086698] [Reference Citation Analysis]
11 Dolphin W, Newhart M. Cannabis Use and Mental Health: Paradoxes of Medicalization. Troubled Persons Industries 2022. [DOI: 10.1007/978-3-030-83745-7_11] [Reference Citation Analysis]
12 Egaña-Huguet J, Soria-Gómez E, Grandes P. The Endocannabinoid System in Glial Cells and Their Profitable Interactions to Treat Epilepsy: Evidence from Animal Models. Int J Mol Sci 2021;22:13231. [PMID: 34948035 DOI: 10.3390/ijms222413231] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Fowler C. The Use of Marijuana Derivatives in Primary Care: An Evidence-Based Approach to Cannabidiol. The Journal for Nurse Practitioners 2021;17:1058-1063. [DOI: 10.1016/j.nurpra.2021.07.011] [Reference Citation Analysis]
14 Vitale RM, Iannotti FA, Schiano Moriello A, Tunisi L, Piscitelli F, Savopoulos R, Cristino L, De Petrocellis L, Amodeo P, Gray R, Di Marzo V. Identification and Characterization of Cannabidiol as an OX1R Antagonist by Computational and In Vitro Functional Validation. Biomolecules 2021;11:1134. [PMID: 34439801 DOI: 10.3390/biom11081134] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
15 Li H, Chang S, Chang T, You Y, Wang X, Wang L, Yuan X, Tan M, Wang P, Xu P, Gao W, Zhao Q, Zhao B. Inclusion complexes of cannabidiol with β-cyclodextrin and its derivative: Physicochemical properties, water solubility, and antioxidant activity. Journal of Molecular Liquids 2021;334:116070. [DOI: 10.1016/j.molliq.2021.116070] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
16 Kolongowski B, Tjiattas-saleski L. Cannabidiol: Background and Literature Review of Potential Treatments. OFP 2021. [DOI: 10.33181/13022] [Reference Citation Analysis]
17 Kloiber S, Matheson J, Kim HK, Le Foll B. Cannabinoid Drugs in Mental Health Disorders. NeuroPsychopharmacotherapy 2021. [DOI: 10.1007/978-3-319-56015-1_465-1] [Reference Citation Analysis]
18 Joca S, Silote GP, Sartim A, Sales A, Guimarães F, Wegener G. Putative effects of cannabidiol in depression and synaptic plasticity. The Neuroscience of Depression 2021. [DOI: 10.1016/b978-0-12-817933-8.00052-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Morales P, Jagerovic N. Synthetic and Natural Derivatives of Cannabidiol. Adv Exp Med Biol 2021;1297:11-25. [PMID: 33537934 DOI: 10.1007/978-3-030-61663-2_2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
20 Galaj E, Xi ZX. Possible Receptor Mechanisms Underlying Cannabidiol Effects on Addictive-like Behaviors in Experimental Animals. Int J Mol Sci 2020;22:E134. [PMID: 33374481 DOI: 10.3390/ijms22010134] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]
21 Ioannidis K, Dadiotis E, Mitsis V, Melliou E, Magiatis P. Biotechnological Approaches on Two High CBD and CBG Cannabis sativa L. (Cannabaceae) Varieties: In Vitro Regeneration and Phytochemical Consistency Evaluation of Micropropagated Plants Using Quantitative 1H-NMR. Molecules 2020;25:E5928. [PMID: 33333745 DOI: 10.3390/molecules25245928] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
22 Wanner NM, Colwell M, Drown C, Faulk C. Subacute cannabidiol alters genome-wide DNA methylation in adult mouse hippocampus. Environ Mol Mutagen 2020;61:890-900. [PMID: 32579259 DOI: 10.1002/em.22396] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
23 Wiley JL, Gourdet CK, Thomas BF. Cannabidiol: Science, Marketing, and Legal Perspectives. 2020. [DOI: 10.3768/rtipress.2020.op.0065.2004] [Reference Citation Analysis]
24 Menne V, Chesworth R. Schizophrenia and drug addiction comorbidity: recent advances in our understanding of behavioural susceptibility and neural mechanisms. nab 2020;2:e10. [DOI: 10.35430/nab.2020.e10] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
25 Khan R, Naveed S, Mian N, Fida A, Raafey MA, Aedma KK. The therapeutic role of Cannabidiol in mental health: a systematic review. J Cannabis Res 2020;2:2. [PMID: 33526132 DOI: 10.1186/s42238-019-0012-y] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 9.0] [Reference Citation Analysis]
26 Dos Santos RG, de Lima Osório F, Martin-Santos R, Zuardi AW, Hallak JEC, Crippa JAS. Modulation of the Endocannabinoid and Oxytocinergic Systems as a Potential Treatment Approach for Social Anxiety Disorder. CNS Drugs 2019;33:1031-8. [PMID: 31617149 DOI: 10.1007/s40263-019-00669-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
27 Minichino A, Senior M, Brondino N, Zhang SH, Godwlewska BR, Burnet PWJ, Cipriani A, Lennox BR. Measuring Disturbance of the Endocannabinoid System in Psychosis: A Systematic Review and Meta-analysis. JAMA Psychiatry 2019;76:914-23. [PMID: 31166595 DOI: 10.1001/jamapsychiatry.2019.0970] [Cited by in Crossref: 57] [Cited by in F6Publishing: 56] [Article Influence: 14.3] [Reference Citation Analysis]
28 Galaj E, Bi GH, Yang HJ, Xi ZX. Cannabidiol attenuates the rewarding effects of cocaine in rats by CB2, 5-HT1A and TRPV1 receptor mechanisms. Neuropharmacology 2020;167:107740. [PMID: 31437433 DOI: 10.1016/j.neuropharm.2019.107740] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 12.0] [Reference Citation Analysis]
29 Calpe-López C, García-Pardo MP, Aguilar MA. Cannabidiol Treatment Might Promote Resilience to Cocaine and Methamphetamine Use Disorders: A Review of Possible Mechanisms. Molecules 2019;24:E2583. [PMID: 31315244 DOI: 10.3390/molecules24142583] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 10.3] [Reference Citation Analysis]
30 Crippa JAS, Hallak JEC, Zuardi AW, Guimarães FS, Tumas V, Dos Santos RG. Is cannabidiol the ideal drug to treat non-motor Parkinson's disease symptoms? Eur Arch Psychiatry Clin Neurosci 2019;269:121-33. [PMID: 30706171 DOI: 10.1007/s00406-019-00982-6] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 7.8] [Reference Citation Analysis]
31 The Effect of Cannabidiol on Psychosis-like Behaviour Induced by Methamphetamine and MK-801 in Mice: A Negative Report. J Psychiatry Brain Sci 2019. [DOI: 10.20900/jpbs.20190006] [Reference Citation Analysis]
32 Rădoi V, Cicu G. Cannabidiol – decades of research and current clinical uses. Psihiatru ro 2019;4:10. [DOI: 10.26416/psih.59.4.2019.2605] [Reference Citation Analysis]
33 Costantino AG, Altomare C, Stella A. Issues of false negative results in toxicology. Accurate Results in the Clinical Laboratory 2019. [DOI: 10.1016/b978-0-12-813776-5.00016-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
34 Scherma M, Masia P, Deidda M, Fratta W, Tanda G, Fadda P. New Perspectives on the Use of Cannabis in the Treatment of Psychiatric Disorders. Medicines (Basel) 2018;5:E107. [PMID: 30279403 DOI: 10.3390/medicines5040107] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]